Optimization of osmotic shock process variables for enhancement of the release of periplasmic interferon-α2b from Escherichia coli using response surface method

Process Biochemistry

Volumn 45, Issue 2, 2010, Pages 196-202

  Ramanan, Ramakrishnan Nagasundara ^a   Tan, Joo Shun ^a   Mohamed, Mohd Shamzi ^a   Ling, Tau Chuan ^a   Tey, Beng Ti ^a   Ariff, Arbakariya B ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Escherichia coli; Interferon 2b; Osmotic shock; Periplasm; Process optimization; Response surface methodology

Indexed keywords

BUFFER CONCENTRATIONS; CELL CONCENTRATIONS; CENTRAL COMPOSITE DESIGNS; COLD WATERS; CONTACT TIME; OPTIMIZED PROCESS; OSMOTIC SHOCKS; PERIPLASM; PLACKETT-BURMAN DESIGNS; PROCESS OPTIMIZATION; PROCESS PARAMETERS; PROCESS VARIABLES; PRODUCT CONCENTRATION; RECOMBINANT HUMAN INTERFERON; RESPONSE SURFACE METHOD; RESPONSE SURFACE METHODOLOGY; SUCROSE CONCENTRATION;

ANTIBIOTICS; CONCENTRATION (PROCESS); ESCHERICHIA COLI; GLYCOPROTEINS; INTERFERONS; OSMOSIS; PROCESS CONTROL; SUGAR (SUCROSE); SURFACE PROPERTIES;

OPTIMIZATION;

ESCHERICHIA COLI;

EID: 71249084292     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2009.09.007     Document Type: Article

References (24)

1. Bargiggia S., Thorburn D., Anderloni A., Ardizzone S., Giorgi A., Porro G.B., et al. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Aliment Pharmacol Ther 22 (2005) 209-215
2. Billiau A. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects. J Clin Virol 39 (2007) 241-265
3. Lanford R.E., Guerra B., Lee H., Averett D.R., Pfeiffer B., Chavez D., et al. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77 (2003) 1092-1104
4. Mazzoran L., Zorat F., Chemello L., Croce L.S., Rigato I., Cavalleto L., et al. Human leucocyte interferon-alpha in the treatment of chronic hepatitis C. Dig Liver Dis 33 (2001) 347-352
5. Rang A., Günther S., and Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J Hepatol 31 (1999) 791-799
6. Schumann W., and Ferreira L.C.S. Production of recombinant proteins in Escherichia coli. Genet Mol Biol 27 (2004) 442-453
7. Hannig G., and Makrides S.C. Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol 16 (1998) 54-60
8. Balasundaram B., and Harrison S.T.L. Influence of the extent of disruption of Bakers' yeast on protein adsorption in expanded beds. J Biotechnol 133 (2008) 360-369
9. Ramanan R.N., Tey B.T., Ling T.C., and Ariff A.B. Classification of pressure range based on the characterization of Escherichia coli cell disruption in high pressure homogenizer. Am J Biochem Biotechnol 5 (2009) 21-29
10. Balasundaram B., and Pandit A.B. Selective release of invertase by hydrodynamic cavitation. Biochem Eng J 8 (2001) 251-256
11. Balasundaram B., and Harrison S.T.L. Study of physical and biological factors involved in the disruption of E. coli by hydrodynamic cavitation. Biotechnol Prog 22 (2006) 907-913
12. Bakir U., and Hamamci H. The effect of freeze-thawing on the release of intracellular proteins from Escherichia coli by means of a bead mill. World J Microbiol Biotechnol 13 (1997) 475-477
13. Anraku Y., and Heppel L.A. On the nature of the changes induced in Escherichia coli by osmotic shock. J Biol Chem 242 (1967) 2561-2569
14. Neu H.C., and Heppel L.A. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem 240 (1965) 3685-3692
15. Neu H.C., and Heppel L.A. The release of ribonuclease into the medium when Escherichia coli cells are converted to spheroplasts. J Biol Chem 239 (1964) 3893-3900
16. Nossal N.G., and Heppel L.A. The release of enzymes by osmotic shock from Escherichia coli in exponential phase. J Biol Chem 241 (1966) 3055-3062
17. Bayer M.E. Response of cell walls of Escherichia coli to a sudden reduction of environmental osmotic pressure. J Bacteriol 93 (1967) 1104-1112
18. Chen Y.C., Chen L.A., Chen S.J., Chang M.C., and Chen T.L. A modified osmotic shock for periplasmic release of a recombinant creatinase from Escherichia coli. Biochem Eng J 19 (2004) 211-215
19. Rastgar Jazii F., Karkhane A.A., Yakhchali B., Fatemi S.S., and Deezagi A. A simplified purification procedure for recombinant human granulocyte macrophage-colony stimulating factor from periplasmic space of Escherichia coli. J Chromatogr B 856 (2007) 214-221
20. Rathore A.S., Bilbrey R.E., and Steinmeyer D.E. Optimization of an osmotic shock procedure for isolation of a protein product expressed in E. coli. Biotechnol Prog 19 (2003) 1541-1546
21. Guo Q.-R., Wei D.-Z., and Tong W.-Y. Partial purification of human parathyroid hormone 1-84 as a thioredoxin fusion form in recombinant Escherichia coli by thermoosmotic shock. Protein Expr Purif 49 (2006) 32-38
22. Rodriguez M., Gu{combining double acute accent}ereca L., Valle F., Quintero R., and Lo{horn}pez-Munguia A. Penicillin acylase extraction by osmotic shock. Process Biochem 27 (1992) 217-223
23. Middelberg A.P.J. Process-scale disruption of microorganisms. Biotechnol Adv 13 (1995) 491-551
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254